当前位置:首页 - 行情中心 - 益丰药房(603939) - 财务分析 - 现金流量表

益丰药房

(603939)

  

流通市值:297.64亿  总市值:297.65亿
流通股本:12.12亿   总股本:12.12亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金19,024,372,147.8712,970,362,874.416,655,595,055.9725,476,899,360.23
  收到其他与经营活动有关的现金324,699,961.01292,322,002.0844,426,798.87288,148,116.91
  经营活动现金流入小计19,349,072,108.8813,262,684,876.496,700,021,854.8425,765,047,477.14
  购买商品、接受劳务支付的现金12,039,371,038.98,342,308,188.843,662,301,479.4614,557,574,284.25
  支付给职工以及为职工支付的现金3,015,007,149.62,069,087,898.961,198,067,921.613,939,587,865.71
  支付的各项税费1,035,250,760.61720,530,230.58306,906,979.331,327,948,156.21
  支付其他与经营活动有关的现金992,232,141.96561,092,769.92418,359,782.861,718,670,086.44
  经营活动现金流出小计17,081,861,091.0711,693,019,088.35,585,636,163.2621,543,780,392.61
  经营活动产生的现金流量净额2,267,211,017.811,569,665,788.191,114,385,691.584,221,267,084.53
二、投资活动产生的现金流量:
  收回投资收到的现金432,639,550.39--7,104,317.53
  取得投资收益收到的现金12,813,00012,813,000-17,084,000
  处置固定资产、无形资产和其他长期资产收回的现金净额1,562,120.081,130,146.661,026,497.4966,273,150.18
  处置子公司及其他营业单位收到的现金净额1,200,000---
  收到的其他与投资活动有关的现金22,169,996,726.0315,323,272,808.136,050,272,846.1816,015,012,371.92
  投资活动现金流入小计22,618,211,396.515,337,215,954.796,051,299,343.6716,105,473,839.63
  购建固定资产、无形资产和其他长期资产支付的现金108,169,339.7263,360,568.8953,604,459.82682,673,370.81
  取得子公司及其他营业单位支付的现金120,448,134.62105,199,954.0864,847,698.15254,664,562.64
  支付其他与投资活动有关的现金22,752,770,00015,384,600,0006,126,500,00018,776,985,007.48
  投资活动现金流出小计22,981,387,474.3415,553,160,522.976,244,952,157.9719,714,322,940.93
  投资活动产生的现金流量净额-363,176,077.84-215,944,568.18-193,652,814.3-3,608,849,101.3
三、筹资活动产生的现金流量:
  吸收投资收到的现金1,753,0001,753,000-5,938,756.58
  其中:子公司吸收少数股东投资收到的现金1,753,0001,753,000-5,938,756.58
  取得借款收到的现金---30,000,000
  收到其他与筹资活动有关的现金---1,783,932,000
  筹资活动现金流入平衡项目00-0
  筹资活动现金流入小计1,753,0001,753,000-1,819,870,756.58
  偿还债务支付的现金71,429,093.461,429,093.461,429,093.4175,337,093.4
  分配股利、利润或偿付利息支付的现金914,684,834.87494,902,456.924,063,315.98951,468,847.52
  其中:子公司支付给少数股东的股利、利润59,810,385.754,179,101.783,961,138.92104,925,012.93
  支付其他与筹资活动有关的现金1,091,414,192.98740,812,474.92375,295,058.231,613,265,067.97
  筹资活动现金流出小计2,077,528,121.251,297,144,025.24440,787,467.612,740,071,008.89
  筹资活动产生的现金流量净额-2,075,775,121.25-1,295,391,025.24-440,787,467.61-920,200,252.31
五、现金及现金等价物净增加额-171,740,181.2858,330,194.77479,945,409.67-307,782,269.08
  加:期初现金及现金等价物余额2,160,797,870.522,160,797,870.522,160,797,870.522,468,580,139.6
  期末现金及现金等价物余额1,989,057,689.242,219,128,065.292,640,743,280.192,160,797,870.52
补充资料:
  净利润-945,793,936.37-1,652,782,285.86
  资产减值准备-46,492,233.84-102,396,476.85
  固定资产和投资性房地产折旧-119,655,431-239,555,369.91
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-119,655,431-239,555,369.91
  无形资产摊销-17,726,568.46-32,025,308.07
  长期待摊费用摊销-107,007,981.24-264,925,013.28
  处置固定资产、无形资产和其他长期资产的损失--33,874,543.07--49,938,810.67
  固定资产报废损失-1,036,265.72-3,836,499.95
  财务费用-101,032,831.38-174,148,877.4
  投资损失--69,308,547.03--108,128,784.49
  递延所得税-4,914,715.32--12,515,021.8
  其中:递延所得税资产减少-6,944,265.85-5,971,649.51
    递延所得税负债增加--2,029,550.53--18,486,671.31
  存货的减少-292,970,637.87--790,972,542.4
  经营性应收项目的减少-1,051,733,287.64--554,453,059.73
  经营性应付项目的增加--1,749,881,096.93-1,593,308,427.28
  其他-824,451.76-65,423,461.4
  现金的期末余额-2,219,128,065.29-2,160,797,870.52
  减:现金的期初余额-2,160,797,870.52-2,468,580,139.6
  现金及现金等价物的净增加额-58,330,194.77--307,782,269.08
公告日期2025-10-302025-08-292025-04-292025-04-29
审计意见(境内)标准无保留意见
TOP↑